• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

孕期疟疾预防与新生儿体重和死亡率的关系:非洲 32 个国家横断面数据集的荟萃分析

Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa.

机构信息

Department of Global Health Systems and Development, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA 70112, USA.

出版信息

Lancet Infect Dis. 2012 Dec;12(12):942-9. doi: 10.1016/S1473-3099(12)70222-0. Epub 2012 Sep 18.

DOI:10.1016/S1473-3099(12)70222-0
PMID:22995852
Abstract

BACKGROUND

Low birthweight is a significant risk factor for neonatal and infant death. A prominent cause of low birthweight is infection with Plasmodium falciparum during pregnancy. Antimalarial intermittent preventive therapy in pregnancy (IPTp) and insecticide-treated mosquito nets (ITNs) significantly reduce the risk of low birthweight in regions of stable malaria transmission. We aimed to assess the effectiveness of malaria prevention in pregnancy (IPTp or ITNs) at preventing low birthweight and neonatal mortality under routine programme conditions in malaria endemic countries of Africa.

METHODS

We used a retrospective birth cohort from national cross-sectional datasets in 25 African countries from 2000-10. We used all available datasets from multiple indicator cluster surveys, demographic and health surveys, malaria indicator surveys, and AIDS indicator surveys that were publically available as of 2011. We tried to limit confounding bias through exact matching on potential confounding factors associated with both exposure to malaria prevention (ITNs or IPTp with sulfadoxine-pyrimethamine) in pregnancy and birth outcomes, including local malaria transmission, neonatal tetanus vaccination, maternal age and education, and household wealth. We used a logistic regression model to test for associations between malaria prevention in pregnancy and low birthweight, and a Poisson model for the outcome of neonatal mortality. Both models incorporated the matched strata as a random effect, while accounting for additional potential confounding factors with fixed effect covariates.

FINDINGS

We analysed 32 national cross-sectional datasets. Exposure of women in their first or second pregnancy to full malaria prevention with IPTp or ITNs was significantly associated with decreased risk of neonatal mortality (protective efficacy [PE] 18%, 95% CI 4-30; incidence rate ratio [IRR] 0·820, 95% CI 0·698-0·962), compared with newborn babies of mothers with no protection, after exact matching and controlling for potential confounding factors. Compared with women with no protection, exposure of pregnant women during their first two pregnancies to full malaria prevention in pregnancy through IPTp or ITNs was significantly associated with reduced odds of low birthweight (PE 21%, 14-27; IRR 0·792, 0·732-0·857), as measured by a combination of weight and birth size perceived by the mother, after exact matching and controlling for potential confounding factors.

INTERPRETATION

Malaria prevention in pregnancy is associated with substantial reductions in neonatal mortality and low birthweight under routine malaria control programme conditions. Malaria control programmes should strive to achieve full protection in pregnant women by both IPTp and ITNs to maximise their benefits. Despite an attempt to mitigate bias and potential confounding by matching women on factors thought to be associated with access to malaria prevention in pregnancy and birth outcomes, some level of confounding bias possibly remains.

摘要

背景

低出生体重是新生儿和婴儿死亡的一个重要危险因素。导致低出生体重的一个主要原因是孕妇在怀孕期间感染疟原虫恶性疟。在疟疾稳定传播地区,孕妇接受抗疟药间歇性预防治疗(IPTp)和经杀虫剂处理的蚊帐(ITN)可显著降低低出生体重的风险。我们旨在评估在疟疾流行国家常规规划条件下,孕妇疟疾预防(IPTp 或 ITN)在预防低出生体重和新生儿死亡方面的有效性。

方法

我们使用了来自 2000-10 年非洲 25 个国家的全国性横断面数据集的回顾性出生队列。我们使用了来自多个指标群集调查、人口与健康调查、疟疾指标调查和艾滋病指标调查的所有可用数据集,这些数据截至 2011 年都是公开的。我们试图通过对与妊娠期间疟疾预防(ITN 或 IPTp 联合磺胺多辛-乙胺嘧啶)和分娩结局相关的潜在混杂因素进行精确匹配,来限制混杂偏倚,这些因素包括当地疟疾传播、新生儿破伤风疫苗接种、产妇年龄和教育程度以及家庭财富。我们使用逻辑回归模型来检验孕妇疟疾预防与低出生体重之间的关联,以及使用泊松模型来检验新生儿死亡率的结局。这两个模型都将匹配层作为随机效应,同时通过固定效应协变量来考虑其他潜在的混杂因素。

结果

我们分析了 32 个国家的横断面数据集。在首次或第二次妊娠期间接受完全疟疾预防的孕妇(接受 IPTp 或 ITN)与新生儿死亡风险降低相关(保护效力[PE]为 18%,95%CI 4-30;发病率比[IRR]为 0.820,95%CI 0.698-0.962),与未受保护的母亲所生的新生儿相比,在进行精确匹配并控制潜在混杂因素后。与未受保护的孕妇相比,在首次和第二次妊娠期间接受完全疟疾预防的孕妇,通过 IPTp 或 ITN 接受孕妇疟疾预防,与降低低出生体重的几率相关(PE 为 21%,14-27;IRR 为 0.792,0.732-0.857),这是通过母亲感知的体重和出生大小的组合来衡量的,在进行精确匹配并控制潜在混杂因素后。

解释

孕妇疟疾预防与常规疟疾控制规划条件下的新生儿死亡率和低出生体重的显著降低相关。疟疾控制规划应努力通过 IPTp 和 ITN 为孕妇提供全面保护,以最大限度地发挥其效益。尽管我们试图通过匹配认为与孕妇获得疟疾预防和分娩结局相关的因素来减轻偏差和潜在混杂的影响,但可能仍存在一定程度的混杂偏倚。

相似文献

1
Malaria prevention in pregnancy, birthweight, and neonatal mortality: a meta-analysis of 32 national cross-sectional datasets in Africa.孕期疟疾预防与新生儿体重和死亡率的关系:非洲 32 个国家横断面数据集的荟萃分析
Lancet Infect Dis. 2012 Dec;12(12):942-9. doi: 10.1016/S1473-3099(12)70222-0. Epub 2012 Sep 18.
2
Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.周效磺胺/乙胺嘧啶的安全性与毒性:对孕期疟疾预防中使用间歇性预防治疗的启示
Drug Saf. 2007;30(6):481-501. doi: 10.2165/00002018-200730060-00003.
3
Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on placental malaria, maternal anaemia and birthweight in areas with high and low malaria transmission intensity in Tanzania.在坦桑尼亚疟疾传播强度高和低的地区,妊娠期间用磺胺多辛-乙胺嘧啶间歇性预防治疗对胎盘疟疾、产妇贫血和出生体重的影响。
Trop Med Int Health. 2014 Sep;19(9):1048-56. doi: 10.1111/tmi.12349. Epub 2014 Jun 26.
4
Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis.恶性疟原虫磺胺多辛-乙胺嘧啶耐药对非洲孕妇疟疾间歇性预防治疗效果的影响:系统评价和荟萃分析。
Lancet Infect Dis. 2019 May;19(5):546-556. doi: 10.1016/S1473-3099(18)30732-1. Epub 2019 Mar 25.
5
Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal.在塞内加尔农村地区的一个区级卫生中心实施孕期用周效磺胺/乙胺嘧啶进行间歇性预防治疗(IPTp-SP)。
Malar J. 2008 Nov 7;7:234. doi: 10.1186/1475-2875-7-234.
6
From evidence to action? Challenges to policy change and programme delivery for malaria in pregnancy.从证据到行动?孕期疟疾政策变革与项目实施面临的挑战。
Lancet Infect Dis. 2007 Feb;7(2):145-55. doi: 10.1016/S1473-3099(07)70026-9.
7
Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.马拉维针对感染和未感染艾滋病毒的孕妇,开展两剂次与每月一次磺胺多辛-乙胺嘧啶间歇性预防治疗疟疾的随机试验。
J Infect Dis. 2006 Aug 1;194(3):286-93. doi: 10.1086/505080. Epub 2006 Jun 20.
8
Malaria prevention during pregnancy: assessing the disease burden one year after implementing a program of intermittent preventive treatment in Koupela District, Burkina Faso.孕期疟疾预防:在布基纳法索库佩拉区实施间歇性预防治疗方案一年后评估疾病负担
Am J Trop Med Hyg. 2006 Aug;75(2):205-11.
9
Coverage of intermittent preventive treatment and insecticide-treated nets for the control of malaria during pregnancy in sub-Saharan Africa: a synthesis and meta-analysis of national survey data, 2009-11.撒哈拉以南非洲地区孕妇疟疾间歇性预防治疗和经杀虫剂处理的蚊帐覆盖情况:2009-2011 年国家调查数据的综合和荟萃分析。
Lancet Infect Dis. 2013 Dec;13(12):1029-42. doi: 10.1016/S1473-3099(13)70199-3. Epub 2013 Sep 18.
10
Cost-effectiveness of two versus three or more doses of intermittent preventive treatment for malaria during pregnancy in sub-Saharan Africa: a modelling study of meta-analysis and cost data.撒哈拉以南非洲地区妊娠期间使用两种与三种或更多剂量间歇性预防治疗疟疾的成本效益比较:基于荟萃分析和成本数据的模型研究。
Lancet Glob Health. 2015 Mar;3(3):e143-53. doi: 10.1016/S2214-109X(14)70385-7.

引用本文的文献

1
Do women attending antenatal clinics who use only intermittent preventive treatment (IPTp) have higher Plasmodium falciparum prevalence compared to those who used both IPTp and slept under insecticide-treated nets?与同时使用间歇性预防治疗(IPTp)和睡在经杀虫剂处理的蚊帐下的孕妇相比,仅使用间歇性预防治疗(IPTp)的产前检查诊所孕妇的恶性疟原虫感染率是否更高?
Malar J. 2025 Aug 28;24(1):275. doi: 10.1186/s12936-025-05532-1.
2
Malaria and anaemia prevalence and associated factors among pregnant women initiating antenatal care in two regions in Ghana: an analytical cross-sectional study.加纳两个地区接受产前护理的孕妇中疟疾和贫血症的患病率及相关因素:一项分析性横断面研究。
BMC Pregnancy Childbirth. 2025 May 27;25(1):617. doi: 10.1186/s12884-025-07735-5.
3
Current update on malaria in pregnancy: a systematic review.孕期疟疾的最新情况:一项系统综述。
Trop Dis Travel Med Vaccines. 2025 May 22;11(1):14. doi: 10.1186/s40794-025-00248-1.
4
Sex of household head and trends in uptake of sulfadoxine-pyrimethamine intermittent preventive treatment for malaria during pregnancy: insights from secondary data in sub-Saharan Africa.户主性别与孕期疟疾磺胺多辛-乙胺嘧啶间歇性预防治疗的使用趋势:撒哈拉以南非洲地区二手数据的见解
Discov Soc Sci Health. 2025;5(1):43. doi: 10.1007/s44155-025-00184-7. Epub 2025 Mar 28.
5
Placental malaria infection is associated with downregulation of STAT-6 and ANG-1 in decidual macrophages.胎盘疟疾感染与蜕膜巨噬细胞中STAT-6和ANG-1的下调有关。
Front Immunol. 2025 Feb 11;16:1497936. doi: 10.3389/fimmu.2025.1497936. eCollection 2025.
6
Acceptability of intermittent preventive treatment of malaria in pregnancy with sulfadoxine-pyrimethamine plus dihydroartemisinin-piperaquine in Papua New Guinea: a qualitative study.在巴布亚新几内亚使用周效磺胺-乙胺嘧啶加双氢青蒿素-哌喹进行孕期疟疾间歇性预防治疗的可接受性:一项定性研究
Malar J. 2025 Jan 13;24(1):13. doi: 10.1186/s12936-024-05233-1.
7
Factors associated with malaria in pregnancy among women attending ANC clinics in selected districts of the Ashanti Region, Ghana.加纳阿散蒂地区部分地区参加产前保健诊所的孕妇中与孕期疟疾相关的因素。
Malar J. 2025 Jan 11;24(1):8. doi: 10.1186/s12936-025-05244-6.
8
Prevalence of molecular markers of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from West Africa during 2012-2022.2012-2022 年期间西非地区疟原虫分离株中磺胺多辛-乙胺嘧啶耐药相关分子标志物的流行情况。
Sci Rep. 2024 Nov 4;14(1):26567. doi: 10.1038/s41598-024-75828-w.
9
Intermittent preventive treatment regimens for malaria in HIV-positive pregnant women.HIV 阳性孕妇的疟疾间歇性预防治疗方案。
Cochrane Database Syst Rev. 2024 Sep 26;9(9):CD006689. doi: 10.1002/14651858.CD006689.pub3.
10
PfEMP1 and var genes - Still of key importance in Plasmodium falciparum malaria pathogenesis and immunity.PfEMP1 和 var 基因——在恶性疟原虫致病机制和免疫中仍然具有关键重要性。
Adv Parasitol. 2024;125:53-103. doi: 10.1016/bs.apar.2024.02.001. Epub 2024 Mar 23.